DFNA5 Antikörper (N-Term)
Kurzübersicht für DFNA5 Antikörper (N-Term) (ABIN452909)
Target
Alle DFNA5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- This antibody detects Dfna5 at N-term.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Aufreinigung
- Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
-
Immunogen
- KLH conjugated synthetic peptide selected from the N-terminal region of human DFNA5
-
-
-
-
Applikationshinweise
-
Western blot: 1: 50 - 1: 100. ELISA: 1: 1,000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
-
- DFNA5 (Deafness, Autosomal Dominant 5 (DFNA5))
-
Andere Bezeichnung
- DFNA5
-
Hintergrund
- Hearing impairment is a heterogeneous condition with over 40 loci described. DFNA5 is expressed in fetal cochlea, however, its function is not known.Synonyms: Dfna5h, ICERE-1, ICERE1, Inversely correlated with estrogen receptor expression 1, Non-syndromic hearing impairment protein 5
-
Molekulargewicht
- 54555 Da
-
Gen-ID
- 1687
-
NCBI Accession
- NP_001120925
-
UniProt
- O60443
-
Pathways
- Sensory Perception of Sound
Target
-